Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report
Cureus · 12.04.2026
DOI: 10.7759/cureus.106907 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 12.04.2026. Verfasst von Anushareddy Muddasani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.
- Pharmacology, University of Arkansas for Medical Sciences, Little Rock, USA.
- Pathology, University of Arkansas for Medical Sciences, Little Rock, USA.
- Hematology and Oncology, University of Arkansas for Medical Sciences, Little Rock, USA.
Zitieren
APA
Muddasani, A., Hendrix, R. J., Laudadio, J., & Gentille, C. (2026). Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report. Cureus. https://doi.org/10.7759/cureus.106907
Vancouver
Muddasani A, Hendrix RJ, Laudadio J, Gentille C. Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report. Cureus. 2026. doi:10.7759/cureus.106907
BibTeX
@article{Muddasani2026,
author = {Muddasani, Anushareddy and Hendrix, Rachel J and Laudadio, Jennifer and Gentille, Cesar},
title = {Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.106907}
}
EUVIMED